By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pulmatrix 

99 Hayden Avenue
Suite 390
Lexington  Massachusetts  02421  U.S.A.
Phone: 781-357-2333 Fax: 781-357-2399


SEARCH JOBS








Company News
Pulmatrix (PULM) Provides 2017 Company Year-To-Date Highlights And Q2 2017 Updated Financials 8/4/2017 11:06:09 AM
Amit D. Munshi Joins Pulmatrix (PULM)'s Board Of Directors 6/16/2017 6:58:48 AM
Pulmatrix (PULM) Licenses Novel Drug Candidates From RespiVert Ltd., A Wholly Owned Subsidiary Of Janssen Biotech (JNJ) 6/13/2017 7:37:21 AM
Pulmatrix (PULM) Receives Key US. Patent For Its Inhaled Drug For COPD 5/9/2017 8:11:05 AM
Pulmatrix (PULM) Reports Q1 2017 Financial Results 5/5/2017 11:17:11 AM
Pulmatrix (PULM) Appoints Ted Raad, MBA, As Chief Business Officer 5/3/2017 8:34:59 AM
Pulmatrix (PULM) Adds Two Top Fungal Infection Experts To Its Scientific Advisory Board 3/27/2017 9:26:02 AM
Pulmatrix (PULM) Receives European Patent For Its Inhaled Drug Delivery Technology 3/21/2017 9:42:26 AM
Pulmatrix (PULM) Reports 2016 Financial Results; Provides 2017 Outlook On Pulmonary Disease Pipeline 3/10/2017 9:10:42 AM
Pulmatrix (PULM) Announces Over $3.0 Million Registered Direct Offering 2/6/2017 6:21:02 AM
123456789
//-->